Elevation Oncology, Inc.
ELEV
$0.381
-$0.0039-1.01%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -47.99M | -44.49M | -41.95M | -39.70M | -39.35M |
| Total Depreciation and Amortization | 19.00K | 24.00K | 29.00K | 33.00K | 39.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.38M | 4.26M | 3.34M | 3.34M | 3.43M |
| Change in Net Operating Assets | 5.09M | 3.84M | 236.00K | -6.99M | -13.04M |
| Cash from Operations | -39.50M | -36.36M | -38.34M | -43.32M | -48.92M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.31M | -8.37M | -13.27M | -48.52M | 5.64M |
| Cash from Investing | -5.31M | -8.37M | -13.27M | -48.52M | 5.64M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.73M | 45.16M | 45.16M | 45.17M | 78.20M |
| Repurchase of Common Stock | -39.00K | -48.00K | -46.00K | -47.00K | -38.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -20.00K | -170.00K | -170.00K | -170.00K | -150.00K |
| Cash from Financing | 14.67M | 44.94M | 44.94M | 44.96M | 78.01M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -30.14M | 209.00K | -6.68M | -46.88M | 34.73M |